EUVIMEDEUVIMED entdecken
Crossref

Epigenetics of cancer drug resistance

Sayandeep Mukherjee, Ronit Dey, Subhabrata Guha, Nabendu Murmu, Gaurav Das

Academia Biology · 2023

DOI: 10.20935/acadbiol6079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academia Biology, 2023. Verfasst von Sayandeep Mukherjee und 4 weiteren Autor:innen. Die Arbeit nennt 81 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the major causes due to cancer-related death is metastasis. The major factors contributing to metastasis of cancer cells are epithelial–mesenchymal transition and cancer stem cells. There are multiple evidences which suggest that malfunction of epigenetic regulation in functioning of a gene is directly related to the development of cancer. The capability to change or reprogram the landscape of epigenetics in the epigenome of cancer is the most promising and guaranteed targeted therapy that leads to the reversibility of drug resistance and new modalities of treatment in cancer. This review clearly focuses on various epigenetic modifications which leads to antitumor drug resistance and how epigenetic modifiers can reverse drug resistance.

Zitieren

APA

Mukherjee, S., Dey, R., Guha, S., Murmu, N., & Das, G. (2023). Epigenetics of cancer drug resistance. Academia Biology. https://doi.org/10.20935/acadbiol6079

Vancouver

Mukherjee S, Dey R, Guha S, Murmu N, Das G. Epigenetics of cancer drug resistance. Academia Biology. 2023. doi:10.20935/acadbiol6079

BibTeX
@article{Mukherjee2023,
  author = {Mukherjee, Sayandeep and Dey, Ronit and Guha, Subhabrata and Murmu, Nabendu and Das, Gaurav},
  title = {Epigenetics of cancer drug resistance},
  journal = {Academia Biology},
  year = {2023},
  doi = {10.20935/acadbiol6079}
}
Kostenlos starten →